PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the sale of the 10th EOS system to the Shriners Hospitals for Children Network in the United States, to be installed in Los Angeles, California. This is the 11th EOS system installed globally in the Shriners Network. In 2011, the first EOS system was acquired by the Shriners Hospital for Children in Montreal, Canada. Shriners Hospitals in the United States started adopting EOS in 2013, and as of today, 10 Shriners sites across the United States have acquired an EOS1.

The 22 Shriners Hospitals for Children prioritize patient safety and clinical excellence. This commitment compelled them to equip their network with EOS systems through a national agreement, which was signed in early 2015. The EOS systems are used as standard of care as the Hospitals provide medical and rehabilitative services to children with osteo-articular conditions, assisting treatment for nearly all pediatric orthopaedic conditions except for traumatic injuries. The hospitals offer a complete range of appropriate medical and rehabilitative services including surgeries; physical, occupational and recreation therapies; and orthotics and prosthetics.

Marie Meynadier, CEO of EOS imaging, said, “When a hospital network as prestigious as the Shriners Hospitals for Children commits to our technology, it’s a big deal. Through this agreement, patients and their families will have a peace of mind knowing that they have access to an imaging system that offers safe, low dose and Micro Dose exams. As many of these children suffer from complex osteo-articular pathologies, they often require frequent imaging exams. We are glad that they won’t need to add the fear of radiation exposure to their already complex concerns.”

__________________________
1 Greenville, South Carolina Portland, Oregon Philadelphia, Pennsylvania Salt Lake City, Utah Spokane, Washington Twin Cities, Minnesota Boston, Massachusetts Chicago, Illinois Lexington, Kentucky Los Angeles, California

For more information, please visit www.eos-imaging.com.

EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris

ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopaedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States (FDA), Japan, China, and the European Union (EC). The Group posted 2015 revenues of €21.8 million and employs 107 people including an R&D team of 39 engineers. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.

Contacts
EOS imaging
Anne Renevot
CFO
+33 (0)1 55 25 61 24
investors@eos-imaging.com
or
NewCap
Financial communication and investor relations
Valentine Brouchot
+33 (0)1 44 71 94 96
eosimaging@newcap.eu
or
The Ruth Group (US)
Press relations / Joanna Zimmerman
646-536-7006
jzimmerman@theruthgroup.com

Hospital Installs Homepage